1,655
Participants
Start Date
May 14, 2020
Primary Completion Date
December 31, 2022
Study Completion Date
Alteplase
Intravenous injection
Karolinska University Hospital, Stockholm
Lead Sponsor
Boehringer Ingelheim
INDUSTRY